Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Dow
McKinsey
Johnson and Johnson
Colorcon

Last Updated: December 8, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR FERRIC DERISOMALTOSE

➤ Subscribe for complete access

« Back to Dashboard

All Clinical Trials for Ferric Derisomaltose

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02642562 ↗ Intravenous Iron Treatment in Patients With Heart Failure and Iron Deficiency: IRONMAN Active, not recruiting NHS Greater Glasgow and Clyde Phase 4 2016-08-01 This study will address whether the additional use of Intravenous (IV) iron on top of standard care will improve the outlook for patients with heart failure and iron deficiency. One group of participants will receive treatment with iron injections and the other group will not receive any iron injections.
NCT02642562 ↗ Intravenous Iron Treatment in Patients With Heart Failure and Iron Deficiency: IRONMAN Active, not recruiting University of Glasgow Phase 4 2016-08-01 This study will address whether the additional use of Intravenous (IV) iron on top of standard care will improve the outlook for patients with heart failure and iron deficiency. One group of participants will receive treatment with iron injections and the other group will not receive any iron injections.
NCT02905539 ↗ A Study Comparing the Iron Substitution With the Medicinal Products Ferinject or Monofer Completed Saarland University Phase 4 2016-07-01 The purpose of this study is to determine to what extend a treatment with the iron compounds Iron Isomaltoside 1000 or Ferric Carboxymaltose is leading to hypophosphatemia and to study the potential clinical impact of hypophosphatemia.
NCT02905539 ↗ A Study Comparing the Iron Substitution With the Medicinal Products Ferinject or Monofer Completed Universit├Ąt des Saarlandes Phase 4 2016-07-01 The purpose of this study is to determine to what extend a treatment with the iron compounds Iron Isomaltoside 1000 or Ferric Carboxymaltose is leading to hypophosphatemia and to study the potential clinical impact of hypophosphatemia.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Ferric Derisomaltose

Condition Name

Condition Name for Ferric Derisomaltose
Intervention Trials
Iron Deficiency Anemia 6
Iron Deficiency Anaemia 5
IDA - Iron Deficiency Anemia 2
Iron-deficiency 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Ferric Derisomaltose
Intervention Trials
Anemia, Iron-Deficiency 9
Anemia 8
Deficiency Diseases 5
Heart Failure 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Ferric Derisomaltose

Trials by Country

Trials by Country for Ferric Derisomaltose
Location Trials
United States 81
United Kingdom 1
Denmark 1
Germany 1
Netherlands 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Ferric Derisomaltose
Location Trials
Florida 5
Texas 4
Louisiana 4
California 4
New Mexico 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Ferric Derisomaltose

Clinical Trial Phase

Clinical Trial Phase for Ferric Derisomaltose
Clinical Trial Phase Trials
Phase 4 5
Phase 3 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Ferric Derisomaltose
Clinical Trial Phase Trials
Completed 6
Enrolling by invitation 1
Not yet recruiting 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Ferric Derisomaltose

Sponsor Name

Sponsor Name for Ferric Derisomaltose
Sponsor Trials
Pharmacosmos A/S 8
National Heart, Lung, and Blood Institute (NHLBI) 1
National Institutes of Health (NIH) 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Ferric Derisomaltose
Sponsor Trials
Other 9
Industry 8
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Express Scripts
Medtronic
McKinsey
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.